Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

MERS-CoV-IN-1

MERS-CoV-IN-1 exhibits excellent inhibitory activity against coronavirus. MERS-CoV-IN-1 is useful as a pharmaceutical composition for preventing coronavirus-induced diseases (MERS-CoV and SARS) (extracted from patent WO2018174442A1, compound 1) [1].

Product Specifications

CAS Number

[2245697-92-9]

UNSPSC

12352005

Target

SARS-CoV

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/mers-cov-in-1.html

Purity

99.53

Solubility

DMSO : 250 mg/mL (ultrasonic)

Smiles

NC1=C(C=CC=C1)COC(C=C2)=CC=C2OC3=CC=CC=C3

Molecular Formula

C19H17NO2

Molecular Weight

291.34

References & Citations

[1]Compound for treating diseases caused by coronavirus infection. Patent WO2018174442A1.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

CAD Mouse Monoclonal Antibody [Clone ID: OTI10A3]
TA812683 100 µL

CAD Mouse Monoclonal Antibody [Clone ID: OTI10A3]

Ask
View Details
2', 3'- O- (Bis- anthraniloyl)adenosine- 5'- O- triphosphate (Bis-ANT-ATP)
MBS256382-01 5 µmol

2', 3'- O- (Bis- anthraniloyl)adenosine- 5'- O- triphosphate (Bis-ANT-ATP)

Ask
View Details
2', 3'- O- (Bis- anthraniloyl)adenosine- 5'- O- triphosphate (Bis-ANT-ATP)
MBS256382-02 5x 5 µmol

2', 3'- O- (Bis- anthraniloyl)adenosine- 5'- O- triphosphate (Bis-ANT-ATP)

Ask
View Details
Polr3k Rat shRNA Plasmid (Locus ID 366277)
TR702375 1 Kit

Polr3k Rat shRNA Plasmid (Locus ID 366277)

Ask
View Details
CD27 Antibody, FITC
MBS1499781-01 0.05 mg

CD27 Antibody, FITC

Ask
View Details
CD27 Antibody, FITC
MBS1499781-02 0.1 mg

CD27 Antibody, FITC

Ask
View Details